Search

everythinglearnresearchcommunity

for

Search:↓

STS01 1% effectively promotes hair regrowth with minimal side effects.

Deucravacitinib did not significantly improve hair regrowth in alopecia areata patients.

3D imaging effectively tracks skin changes in vitiligo treatment.

Topical patidegib gel effectively treats basal cell carcinoma in Gorlin syndrome patients without causing the side effects seen with oral treatments.

Baricitinib is generally safe for long-term use in treating severe alopecia areata.

Guselkumab significantly improves psoriasis symptoms within 12 weeks.

Hair regrowth improved, but quality of life did not.

New anti-acne medications are being tested to offer alternatives to current treatments.

Baricitinib was effective in treating both early and late onset alopecia areata.

Topical treatment SM04554 safely promotes hair growth in male baldness.

Baricitinib is effective and safe for severe alopecia areata, working similarly with or without an atopic background.

Deuruxolitinib effectively regrows hair in adults with alopecia areata and is well tolerated.

Low-dose dutasteride effectively and safely promotes hair growth in men.

ENERGI-F701 solution was found to be more effective and safer than Regaine® 2% minoxidil solution in treating female pattern hair loss, with increased hair density and less side effects.

Ixekizumab is effective and safe for patients who did not improve with etanercept treatment for psoriasis.

SER120 nasal spray effectively reduces nighttime urination and is safe for patients.

Weekly bicalutamide is safe and effective, with 50 mg/week recommended.

5% minoxidil foam effectively treats female hair loss.

Elagolix did not effectively treat polycystic ovary syndrome.

Intense exercise at night can delay the body's internal clock gene expression by 2 to 4 hours.

Further testing of paclitaxel poliglumex for this cancer treatment is not justified.

A trial showed that a new treatment is safe and effective for male pattern baldness, with most participants growing new hair.

CAP7.1 is generally safe at 200 mg/m²/day, but can cause fatigue, nausea, hair loss, fever, and blood-related issues.

Injections of special skin cells showed potential in treating hair loss, with some participants experiencing increased hair density.

The gene therapy showed significant wound healing and was safe for treating severe RDEB.

Tavaborole is a safe and effective toenail fungus treatment, with the 5% solution being the best option.

Oxymetazoline cream 1.0% effectively reduces rosacea redness, and using baseline photos improves assessment accuracy.

Baricitinib significantly regrows hair in teens with severe alopecia areata.

Baricitinib was effective in regrowing eyebrow and eyelash hair in patients with severe alopecia areata.